Status:
COMPLETED
Efficacy of Art Intervention on Decreasing Pain and Anxiety During Intravenous Cannulation
Lead Sponsor:
University of Witten/Herdecke
Conditions:
Catheterization
Pain
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Peripheral Intravenous Cannulation (PIVC), one of the most common therapeutic procedures in medical care, can be difficult even for experienced medical practitioners. The pain of intravenous cannulati...
Detailed Description
Peripheral Intravenous Cannulation (PIVC), one of the most common therapeutic procedures in medical care, can be difficult even for experienced medical practitioners. The pain of intravenous cannulati...
Eligibility Criteria
Inclusion
- Pediatric patients 6-12 years old,
- Pediatric who needed peripheral cannulation,
Exclusion
- Children with chronic conditions,
- impairments physical,
- Disabilities with communicating difficulties,
- Those whose parent not participated,
- Neurodevelopmental delayed, can't verbal speak, hearing or visual impairments,
- Children with coma or drowsiness,
- have to take analgesic medication for less than 6 hrs.
- history of syncope.
Key Trial Info
Start Date :
November 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 5 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04714255
Start Date
November 3 2019
End Date
February 5 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sherzad Suleman
Witten, North Rhine-Westphalia, Germany, 58455